Skip to main content

Caregivers

0
Pipeline Programs
4
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Purdue Pharma
Purdue PharmaCT - Stamford
1 program
Acceptance and Commitment TherapyN/A1 trial
Active Trials
NCT05999448Unknown800Est. Dec 2025
Oregon Therapeutics
Oregon TherapeuticsFrance - Paris
1 program
Acceptance and Commitment TherapyN/A
Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
1 program
Safety in DementiaN/A1 trial
Active Trials
NCT05173922Completed500Est. Oct 2024

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
Purdue PharmaAcceptance and Commitment Therapy
Colorado TherapeuticsSafety in Dementia

Clinical Trials (2)

Total enrollment: 1,300 patients across 2 trials

NCT05999448Purdue PharmaAcceptance and Commitment Therapy

Promoting the Well Being of Caregivers Via Telehealth

Start: Jun 2023Est. completion: Dec 2025800 patients
N/AUnknown

"Safety in Dementia": An Online Caregiver Intervention

Start: May 2022Est. completion: Oct 2024500 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.